Ananth Kadambi
Ananth Kadambi publishes mostly in Economics and Econometrics, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Health Systems, Economic Evaluations, Quality of Life, Angiogenesis and VEGF in Cancer and Cancer, Hypoxia, and Metabolism.
- World rank
- #1,829,940 of 7,710,434 ranked researchers
- Rank in United States
- #561,330 of 1,627,098
- Works
- 40
- Citations
- 2.7k
- Citations per work
- 66.9
What does Ananth Kadambi research?
Ananth Kadambi's work is mostly in Economics, Econometrics and Finance (14%), Medicine (12%), Biochemistry, Genetics and Molecular Biology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2256.2%
- Social Sciences614.3%
- Health Sciences512.4%
- Medicine512.4%
- Life Sciences511.4%
- Physical Sciences25.7%
- Mathematics25.7%
- 1Economics and Econometrics14% of their works
- 2Pulmonary and Respiratory Medicine7% of their works
- 3Cancer Research6% of their works
- 4Statistics and Probability6% of their works
- 5Infectious Diseases6% of their works
- 6Molecular Biology6% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Angiogenesis and VEGF in Cancer
- Cancer, Hypoxia, and Metabolism
- Statistical Methods in Clinical Trials
- Artificial Intelligence in Healthcare and Education
- Pharmaceutical Economics and Policy
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Which keywords describe Ananth Kadambi's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Quality of Life, ACE2 Receptor, SARS-CoV-2, endothelial progenitor cells, VEGF, Adaptive Designs and Artificial Intelligence.
- Vaccine
- Coronavirus
- Warburg Effect
- HIF-1
- False Discovery Rate
- Artificial Intelligence
- endothelial progenitor cells
- SARS-CoV-2
- Quality of Life
- Cost-effectiveness Analysis
- ACE2 Receptor
- VEGF
- Adaptive Designs
- Drug Development Costs
- Generic Drugs
- Machine Learning
- Clinical Characteristics
- Epidemiology
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Cost-effectiveness Analysis91 topic
- Quality of Life91 topic
- ACE2 Receptor62 topics
- SARS-CoV-262 topics
- VEGF51 topic
- endothelial progenitor cells51 topic
- Adaptive Designs41 topic
- Artificial Intelligence41 topic
- Drug Development Costs41 topic
- False Discovery Rate41 topic
- Generic Drugs41 topic
- HIF-141 topic
- Machine Learning41 topic
- Warburg Effect41 topic
- Clinical Characteristics31 topic
- Coronavirus31 topic
- Epidemiology31 topic
- Vaccine31 topic
Where does Ananth Kadambi work?
Ananth Kadambi's main affiliation in the publication record is Ithaka Harbors, United States.
How many publications and citations does Ananth Kadambi have?
OpenAlex counts 40 works and 2,677 citations for Ananth Kadambi, an h-index of 11, ranking #1,829,940 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ananth Kadambi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.